Oct 2026
Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: A Prospective Phase II Study With a Propensity Score-Matched Analysis.
Prolonged preoperative GnP may improve outcomes, suggesting that treatment duration may be a key determinant of efficacy, and survival comparable to historical controls treated with upfront surgery is demonstrated.
K. Ishido, N. Kimura, H. Nagase et al.
· Journal of Surgical Research · 0 citations